, , ,
J Alzheimers Dis 66:517532 Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y, Yoshitome E, Takanashi J, Matsuda T, Shimizu E, Ikehira H, Iyo M, Hashimoto K (2008) Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study
Federal Trade Commission (FTC) announced that the alleged masterminds behind a fraudulent scheme to market two seaweed-based patches as weight-loss products to U.S
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al
The fear of needles: A systematic review and meta-analysis. Journal of Advanced Nursing
55M people globally are affected by dementia, with 70% of that population having Alzheimers disease, which is characterized by the buildup of two proteins in the brain, amyloid and tau